Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianluigi Forloni

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Aging and Disease|May 18, 2023
Oligomers and Neurodegeneration: New EvidenceGianluigi Forloni
International Journal of Molecular Sciences|March 29, 2023
Alpha Synuclein: Neurodegeneration and InflammationGianluigi Forloni
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 14, 2025
Doxycycline: An essential tool for Alzheimer's diseaseGianluigi Forloni
BMJ Neurology Open|March 8, 2021
Alzheimer's disease: from basic science to precision medicine approachGianluigi Forloni
Neuromolecular Medicine|December 15, 2010
APP transgenic mice: their use and limitationsClaudia Balducci, Gianluigi Forloni
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease, Oligomers, and InflammationGianluigi Forloni, Claudia Balducci
Prion|December 15, 2010
β-amyloid oligomers and prion protein: Fatal attraction?Gianluigi Forloni, Claudia Balducci
Current Pharmaceutical Design|July 18, 2013
In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approachesClaudia Balducci, Gianluigi Forloni
Frontiers in Pharmacology|July 24, 2019
Doxycycline for Alzheimer's Disease: Fighting β-Amyloid Oligomers and NeuroinflammationClaudia Balducci, Gianluigi Forloni
Current Pharmaceutical Design|June 23, 2007
JNK signalling: a possible target to prevent neurodegenerationTiziana Borsello, Gianluigi Forloni
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Aging and Disease|May 18, 2023
Oligomers and Neurodegeneration: New EvidenceGianluigi Forloni
International Journal of Molecular Sciences|March 29, 2023
Alpha Synuclein: Neurodegeneration and InflammationGianluigi Forloni
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 14, 2025
Doxycycline: An essential tool for Alzheimer's diseaseGianluigi Forloni
BMJ Neurology Open|March 8, 2021
Alzheimer's disease: from basic science to precision medicine approachGianluigi Forloni
Neuromolecular Medicine|December 15, 2010
APP transgenic mice: their use and limitationsClaudia Balducci, Gianluigi Forloni
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease, Oligomers, and InflammationGianluigi Forloni, Claudia Balducci
Prion|December 15, 2010
β-amyloid oligomers and prion protein: Fatal attraction?Gianluigi Forloni, Claudia Balducci
Current Pharmaceutical Design|July 18, 2013
In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approachesClaudia Balducci, Gianluigi Forloni
Frontiers in Pharmacology|July 24, 2019
Doxycycline for Alzheimer's Disease: Fighting β-Amyloid Oligomers and NeuroinflammationClaudia Balducci, Gianluigi Forloni
Current Pharmaceutical Design|June 23, 2007
JNK signalling: a possible target to prevent neurodegenerationTiziana Borsello, Gianluigi Forloni
Pageof 27